American Regent intros generic potassium phosphates injection

American Regent is offering Potassium Phosphates Injection, which is the generic of Potassium Phosphates.

Potassium Phosphates Injection is indicated as a source of phosphorus in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated; and for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated.

[Read more: Generic sterile injectables market to reach $196.2B by 2029]

"An important part of our company's mission is to assist in mitigating shortages and ensuring supply of critical medications whenever possible," stated Joann Gioia, vice president and chief commercial officer at American Regent. "To that end, we are pleased to add Potassium Phosphates Injection, USP to our robust line of products that are formulated, filled, and finished at our U.S.-based manufacturing facilities."